múltiples favorecen el nacimiento de niños prematuros vulnerables. 19 (21 %) hipertensión pulmonar, 13 (14 %) broncodisplasia pulmonar y dos (2 %). La retinopatía del prematuro (ROP) constituye una de las principales causas de ceguera asociadas (cardiopatías congénitas, broncodisplasia pulmonar, etc.). sepsis, soporte respiratorio, broncodisplasia pulmonar (DBP), ruptura alveolar, retinopatía del prematuro (ROP), días de internación y muerte.

Author: Doucage Nekasa
Country: Ethiopia
Language: English (Spanish)
Genre: Love
Published (Last): 6 February 2006
Pages: 477
PDF File Size: 6.7 Mb
ePub File Size: 9.28 Mb
ISBN: 754-1-12741-824-6
Downloads: 17144
Price: Free* [*Free Regsitration Required]
Uploader: Jushicage

For that reason we review the literature with the objective of showing the anesthetic considerations for the laser treatment of that disease. Broncodislasia T, Bancalari E.

We looked for the theme in books, printed documents and on line, and also in the following databases: Riesgo de muerte p 0, RR 3,5 1,2. Anaesthesia in retinopathy of prematurity treatment.

High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: Expression, activity and function of phosphodiesterases in the mature and immature ductus arteriosus.


Robertson B, Taeusch HW, editors. Pierce MR, Bancalari E.

Orematuros Italiano, Buenos Aires: Bancalari E, del Moral T. Navia esquina Isabel Primera: J Pediatr Child Health. Services on Demand Journal. Cardiovascular effects of surfactant replacement with special reference to the patent ductus arteriosus. Nutrition and bronchopulmonary dysplasia. Anesthesia for laser treatment for retinopathy of prematurity — all clear now?

A survey of eight centers.

Anaesthesia for the laser treatment of neonates with retinopathy of prematurity. Maior peso ao nascer, maior idade gestacional e sexo feminino estiveram associados a um menor risco de displasia broncopulmonar.

[Neonatal morbidity and hospital mortality of preterm triplets.]

Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. De um total de 2. Surfactant therapy for lung disease: Am Rev Respir Dis. Agustina Gonzalez, Ana L. Lung compliance in newborns with patent ductus arteriosus before and after prematurls ligation.

[Neonatal morbidity and hospital mortality of preterm triplets.]

Variation in anaesthesia for the laser treatment of retinopathy of prematurity-a survey of ophthalmologists in prdmaturos UK. Risk factors for chronic lung disease in the surfactant era: Remifentanil in paediatric anaesthetic practice. Is chronic lung disease in low birth weight infants preventable?


Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. Prenatal administration of betamethasone for prevention of patent ductus arteriosus. SIP is associated with early indomethacin exposure. The adverse neuro-developmental effects of broncosisplasia steroids in the preterm broncodisppasia Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks gestation.

Jobe A, Ikegami M. Patent ductus arteriosus a physiological basis for current treatment practices: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Clyman RI, Marayanan M. Este agente tiene algunas ventajas sobre el halotano: